Zogenix, Inc., a privately held pharmaceutical company and Astellas Pharma US, Inc., announced today their exclusive co-promotion agreement for Sumavel DosePro (sumatriptan injection) needle-free delivery system. Sumavel DosePro received FDA approval in July 2009 and is a first-of-its-kind needle-free delivery system for subcutaneous sumatriptan, a treatment that provides migraine relief within 10 minutes for some patients.
The details can be read here.
No comments:
Post a Comment